Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1367 results
Takeda to develop new ADC candidates using Mersana's Fleximer technology
By PBR Staff Writer
US-based Mersana Therapeutics has entered into collaboration with Millennium Pharmaceuticals, a wholly-owned subsidiary of Takeda Pharmaceutical, for the development of next-generation, Fleximer antibody-drug conjugates (ADCs).
Automation > IT & Software > News
Horizon Discovery launches new Genassist CRISPR and rAAV gene editing tools and services
Horizon Discovery has announced the launch of its full range of Genassist gene editing kits, reagents and support services that enable easier, robust implementation of gene editing experiments with CRISPR and rAAV.
Automation > IT & Software > News
Spectromics to develop novel technology for effective use of antibiotics and other antimicrobial therapeutics
University of Manchester spin-out, Spectromics, is set to develop novel technology that will help guide the effective use of antibiotics and other antimicrobial therapeutics.
Automation > IT & Software > News
XBiotech announces in-licensing of technology from Strox Biopharmaceuticals
XBiotech has announced that it acquired the patent estate of Strox Biopharmaceuticals relating to antibody therapies for methicillin resistant staphylococcus aureus (MRSA).
Automation > IT & Software > News
Anaptysbio announces issuance of US patent covering antibody humanization technology
AnaptysBio has announced today that the US Patent and Trademark Office (USPTO) has issued US Patent #8,685,897 broadly covering a novel approach to antibody humanization using somatic hypermutation.
Automation > IT & Software > News
Cancer Genetics expands BioDiscovery’s nexus copy number platform
Cancer Genetics and BioDiscovery have expanded the Nexus Copy Number Discovery platform in CGI research to uncover new biomarkers which are predictive of cancer outcomes.
Automation > IT & Software > News
Alacris to use SAP HANA platform for ModCell system
Alacris Theranostics has entered into a project with SAP to use the SAP HANA platform to enable Alacris' proprietary ModCell system.
Automation > IT & Software > News
Nuvilex retains TD2 to carryout preclinical, clinical studies for treatment of pancreatic cancer
Nuvilex (NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, has signed a Master Services Agreement with Translational Drug Development (TD2) pursuant to which TD2 will conduct preclinical and clinical studies in support of the development of Nuvilex's pancreatic cancer and other treatments utilizing Cell-in-a-Box technology.
Automation > IT & Software > News
Advaxis receives notice of allowance from USPTO for cancer immunotherapy platform technology
Advaxis has announced that the US Patent and Trademark Office (USPTO) has issued a notice of allowance for three US patent applications (12/213,696, 13/254,607, and 11/415,271) with claims of each application related to the company's proprietary cancer immunotherapy platform technology.
Automation > IT & Software > News
GSK uses Novozymes’ VELTIS half-life extension technology in its type 2 diabetes drug
Novozymes Biopharma, a subsidiary of Novozymes, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline (GSK) in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.
Automation > IT & Software > News
Caris Life Sciences improves clinical use of tumor profiling service
Caris Life Sciences, a US-based biosciences firm focused on fulfilling the promise of personalized medicine, continues to enhance its comprehensive tumor profiling service, Caris Molecular Intelligence, now capable of providing an industry-leading 51 drug target associations, including exciting new immunologically-based drug targets.
Automation > IT & Software > News
iBio receives patent allowances for pandemic influenza therapeutics
iBio, a developer of proprietary products and product licenses, based on its proprietary iBioLaunch and iBioModulator platforms, has reported the allowance of two US patents for monoclonal antibodies targeting influenza.
Automation > IT & Software > News
Otsuka, IBM to develop transformative care coordination solution
By PBR Staff Writer
Japan-based Otsuka Pharmaceutical (Otsuka) and US-based multinational technology and consulting firm IBM are teaming up to deliver a new solution to improve care coordination in the mental health community.
Automation > IT & Software > News
NeoStem signs research collaboration agreement for treatment of skin wounds in scleroderma
By PBR Staff Writer
NeoStem has inked an agreement for a research collaboration aimed at investigating the potential of very small embryonic-like stem cells (VSELs) in treating difficult to heal wounds in an animal model of scleroderma.
Automation > IT & Software > News
Access Pharmaceuticals Cobraxane offers enhanced tumor growth inhibition in tumor models
Access Pharmaceuticals has announced that it is leveraging its proprietary CobaCyte drug delivery platform technology to create new formulations of active pharmaceutical agents.
Automation > IT & Software > News
91-105 of 1367 results